ERBB2 and breast cancer: We compared the TGFβ-1, CXCR4, IL19, BMP1, VCAN, and WNT2 expression in different subtypes of breast cancer, and the results demonstrated that BMP1, and WNT2 were consistently overexpressed in HER-2 subtype.